ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 137 filers reported holding ZIOPHARM ONCOLOGY INC in Q3 2018. The put-call ratio across all filers is 1.86 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $128,000 | +120.7% | 74,592 | +39.4% | 0.01% | +100.0% |
Q4 2021 | $58,000 | -46.3% | 53,524 | -10.1% | 0.01% | -40.0% |
Q3 2021 | $108,000 | -57.1% | 59,527 | -15.0% | 0.01% | -44.4% |
Q1 2021 | $252,000 | +563.2% | 69,999 | +364.4% | 0.02% | +157.1% |
Q3 2020 | $38,000 | -63.8% | 15,072 | -38.8% | 0.01% | -12.5% |
Q3 2019 | $105,000 | -69.1% | 24,617 | -57.7% | 0.01% | -60.0% |
Q2 2019 | $340,000 | +92.1% | 58,257 | +27.0% | 0.02% | +100.0% |
Q1 2019 | $177,000 | +45.1% | 45,868 | -29.5% | 0.01% | +42.9% |
Q4 2018 | $122,000 | +205.0% | 65,048 | +395.3% | 0.01% | +250.0% |
Q2 2018 | $40,000 | -65.2% | 13,132 | -55.1% | 0.00% | -66.7% |
Q1 2018 | $115,000 | -71.8% | 29,232 | -70.4% | 0.01% | -72.7% |
Q4 2017 | $408,000 | +558.1% | 98,638 | +877.6% | 0.02% | +633.3% |
Q3 2017 | $62,000 | – | 10,090 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MSD Partners, L.P. | 15,151,516 | $38,182,000 | 7.99% |
DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 10,406,850 | $26,225,000 | 4.02% |
MILLER VALUE PARTNERS, LLC | 12,385,586 | $31,211,000 | 1.12% |
CHIRON CAPITAL MANAGEMENT, LLC | 201,470 | $508,000 | 0.41% |
Sargent Investment Group, LLC | 289,025 | $728,000 | 0.26% |
MAGNOLIA CAPITAL ADVISORS LLC | 80,542 | $404,000 | 0.16% |
XTX MARKETS LLC | 11,086 | $28,000 | 0.14% |
Virtus ETF Advisers LLC | 99,108 | $250,000 | 0.13% |
Old West Investment Management, LLC | 210,226 | $529,000 | 0.12% |
EQUITEC PROPRIETARY MARKETS, LLC | 31,300 | $79,000 | 0.06% |